Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

Eiben, Gretchen L; Velders, Markwin P; Schreiber, Hans; Cassetti, Maria Cristina; Pullen, Jeffrey K; Smith, Larry R; Kast, W Martin

Eiben, Gretchen L; Velders, Markwin P; Schreiber, Hans; Cassetti, Maria Cristina; Pullen, Jeffrey K; Smith, Larry R; Kast, W Martin.

Affiliation

Eiben GL; Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois 60153, USA.

Cancer Res ; 62(20): 5792-9, 2002 Oct 15.

Article in En | MEDLINE | ID: mdl-12384540

Subject(s)

Cancer Vaccines/immunology; Disease Models, Animal; HLA-A Antigens/immunology; Neoplasms, Experimental/immunology; Oncogene Proteins, Viral/immunology; Repressor Proteins; Vaccines, DNA/immunology; Animals; Cancer Vaccines/genetics; Cancer Vaccines/therapeutic use; Encephalitis Virus, Venezuelan Equine; Epitopes/immunology; Female; HLA-A2 Antigen; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental/therapy; Papillomavirus E7 Proteins; Vaccines, DNA/genetics; Vaccines, DNA/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / HLA-A Antigens / Oncogene Proteins, Viral / Cancer Vaccines / Vaccines, DNA / Disease Models, Animal / Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Res Year: 2002 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links